Advances in Treatments of Oral Cancer/Tumor
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".
Deadline for manuscript submissions: closed (29 January 2024) | Viewed by 1723
Special Issue Editors
Interests: oral oncology; regenerative medicine; stem cells
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The standard protocol for the treatment of oral tumors including oral squamous cell carcinoma is surgical resection with adjunct chemotherapy and/or radiotherapy. A common issue with the current treatment protocol is the resistance shown by cancer cells. In addition, radical surgical interventions and the cytotoxic effects of adjunct therapies often lead to significant morbidity, drastically reducing the quality of life. Thus, a modality capable of targeting the cancer cells, overcoming any potential resistance, and minimizing any potential morbidity is needed. Examples of new avenues working in this effort are immunotherapies, gene therapy, and even intraarterial chemotherapy. The main purpose of these novel avenues to treat oral cancer is to improve the survival and quality of life of oral cancer patients. The present Special Issue focuses on innovative research work aimed at developing improved or novel therapeutic strategies targeting oral tumors.
Prof. Dr. Shankargouda Patil
Dr. Claudia M. Tellez Freitas
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Artificial Intelligence
- cancer immunotherapy
- cancer vaccines
- checkpoint inhibitors
- personalized medicine
- target gene therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
